News
Immunotherapy shows promise in metastatic cervical cancer
Key clinical point: Immunotherapy using adoptive T-cell therapy can induce complete remission in metastatic cervical cancer.Major finding: An...
CHICAGO – Research demonstrating that immunotherapy can be harnessed to treat metastatic cervical cancer was one of the highlights of the annual meeting of the American Society of Clinical Oncology.
We spoke with gynecologic cancer expert Dr. Don Dizon to learn more about why human papillomavirus-targeted T-cell therapy could work in cervical cancer and if this same cellular-based approach could be used in other virally mediated tumors.
Dr. Dizon is director of the Oncology Sexual Health Clinic at Massachusetts General Hospital Cancer Center in Boston.
He reported having no financial disclosures.